MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Assessing Disease Progression in MSA: Development of a Bayesian Progression Model

    J. Wiedemann, C. Ebbesen, T. Jensen, M. Quintana, B. Wendelberger, W. Poewe, F. Krismer, S. Zanigni, J. Luthman (Valby, Denmark)

  • Assessing Genome-wide Genetic Risk for Parkinson’s Disease Age at Onset in European Sub-Populations: from the Global Parkinson’s Genetics Program

    GP2. Parkinson'S_genetics_program (Bethesda, USA)

  • Assessing Individual Risk Through Determination of Local Ancestry: Insights from the Global Parkinson’s Genetics Program

    M. Makarious, T. Leal, E. Waldo, D. Vitale, M. Koretsky, S. Hong, S. Yeboah, K. Levine, H. Leonard, M. Nalls, I. Mata, GP2. Parkinson'S_genetics_program (gp2) (Maryland, USA)

  • Assessing Physiotherapy’s Role in Parkinson’s Disease Functionality in India: A Case Report

    K. Thangavelu (Gurugram, India)

  • Assessing the Impact of Interprofessional Education on Collaborative Practice in Neurorehabilitation for Parkinson’s Disease: A Systematic Review

    Y. Hamdi, S. Elsenbawy, G. Abozeid, D. W. Ismail, H. Elshazly, M. Elsayed (Giza, Egypt)

  • Assessing the potential association of rs2298383 in ADORA2A as a predictor of Levodopa-Induced Dyskinesia in Latin American Parkinson’s Disease patients

    HM. Chaparro-Solano, E. Waldo, T. Peixoto-Leal, AF. Schumacher-Schuh, BL. Santos-Lobato, E. Gatto, G. Arboleda, JL. Orozco-Velez, P. Chana-Cuevas, D. Aguillon, M. Rodriguez-Violante, D. Martinez-Ramirez, M. Cornejo-Olivas, A. Vinuela, G. Alvarado, P. Olguín, S. Alcauter, IF. Mata (Cleveland, USA)

  • Assessing the Relationship Between Autonomic Symptom Burden and Autonomic Failure in Parkinson’s Disease

    F. Sadeghifar, N. Browner, E. Dayan, M. Sklerov (Chapel Hill, USA)

  • Assessment of cognitive impairment in Parkinson’s disease in Bangladeshi patients in Dhaka as part of the London-Dhaka Parkinson’s Cognition Study

    A. Haque, K. Dey, T. Zannat, A. Zirra, E. Camboe, S. Waters, D. Mair, T. Haque, C. Marshall, R. Weil, N. Mukadam, A. Noyce, A. Habib (Dhaka, Bangladesh)

  • Assessment of Hypomimia in Parkinson’s Disease

    T. Grover, T. Foltynie, J. Candelario, C. Milabo, C. Girges, M. Salazar, J. Esperida, P. Limousin (London, United Kingdom)

  • Assessment of mitochondrial DNA copy number and common deletion (del4977) as candidate peripheral biomarkers for Spinocerebellar ataxia type 2

    LE. Almaguer Mederos, D. Cuello Almarales, R. Aguilera Rodríguez, D. Almaguer Gotay, DO. Palenzuela Gardon, H. Camacho Rodríguez, A. Estupiñán Rodríguez, N. Canales Ochoa, S. Gispert, G. Auburger (Frankfurt am Main, Germany)

  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley